Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Iradimed (IRMD) over the last 13 years, with Q3 2025 value amounting to $214374.0.

  • Iradimed's Other Non-Current Assets rose 1637.29% to $214374.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $214374.0, marking a year-over-year increase of 1637.29%. This contributed to the annual value of $198912.0 for FY2024, which is 962.42% up from last year.
  • Per Iradimed's latest filing, its Other Non-Current Assets stood at $214374.0 for Q3 2025, which was up 1637.29% from $204499.0 recorded in Q2 2025.
  • In the past 5 years, Iradimed's Other Non-Current Assets registered a high of $648672.0 during Q4 2022, and its lowest value of $172272.0 during Q1 2022.
  • For the 5-year period, Iradimed's Other Non-Current Assets averaged around $244709.6, with its median value being $204499.0 (2025).
  • As far as peak fluctuations go, Iradimed's Other Non-Current Assets soared by 22220.14% in 2022, and later plummeted by 7202.76% in 2023.
  • Over the past 5 years, Iradimed's Other Non-Current Assets (Quarter) stood at $201325.0 in 2021, then soared by 222.2% to $648672.0 in 2022, then plummeted by 72.03% to $181449.0 in 2023, then increased by 9.62% to $198912.0 in 2024, then rose by 7.77% to $214374.0 in 2025.
  • Its Other Non-Current Assets was $214374.0 in Q3 2025, compared to $204499.0 in Q2 2025 and $206009.0 in Q1 2025.